Clinical TrialsSearch results
Number of results: 659
Other
- Does gefitinib prolong the survival of adenocarcinoma patients against non-adeno non-small cell lung cancer? A retrospective study.
- Non-small cell lung cancer
- West Japan Oncology Group
- 2008-07-23
Other
- Phase 3 study of docetaxel vs vinorelbine in elderly patients with advanced non-small cell lung cancer
- elderly patients with advanced non-small cell lung cancer
- West Japan Oncology Group
- 2005-09-06
Other
- Phase III study of gefitinib versus erlotinib in patients with previously treated lung adeno carcinoma
- Previously treated lung adeno carcinoma
- West Japan Oncology Group
- 2009-06-19
Other
- PhaseIII study of gefitinib versus cisplatin plus docetaxel in patients with non-small cell lung cancer with EGFR mutation
- non small cell lung cancer
- West Japan Oncology Group
- 2006-12-11
Other
- Randomized phase III study of nedaplatin plus docetaxel versus cisplatin plus docetaxel for advanced or relapsed squamous cell carcinoma of the lung
- squamous cell carcinoma of the lung
- West Japan Oncology Group
- 2009-06-30
Other
- To evaluate whether two weekly concurrent chemoradiotherapy regimens offer any advantage over concurrent chemoradiotherapy regimens with Cisplatin, Vindesine, Mitomycin for unresectable stage III NSCLC
- unresectable stage III NSCLC
- West Japan Oncology Group
- 2005-08-29
Other
- Physician-initiated clinical trial in patients with 5-aminolevulinic acid-induced ATR-X syndrome.
- ATR-X syndrome
- Wada Takahito
- 2022-07-14
Other
- A comparison of a combination drug of an angiotensin II receptor antagonist and a low-dose diuretic vs. a high-dose angiotensin II receptor antagonist in hypertensive patients
- Hypertension
- Vascular Care Network (VCN) Kamanza study group
- 2008-08-01
Not yet recruiting
- The development of a novel therapy using glycyrrhitinic acid for overactive bladder caused by lower urinary tract obstruction.
- overactive bladder caused by lower urinary tract obstruction
- Urology, Kyoto University
- 2009-11-01
Completed
- CHAT-Lu
- Type2 diabetes mellitus
- Urata Hidenori
- 2019-02-14